Jane Street Group, LLC Cidara Therapeutics, Inc. Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$0.64 - $0.92 $20,468 - $29,423	31,982 Added 232.53%	45,736 $42,000
Q4 2023 Feb 14, 2024	BUY	$0.68 - $0.97 $9,352 - $13,341	13,754 New	13,754 $10,000
Q1 2023 May 15, 2023	BUY	$0.75 - $1.98 $183,033 - $483,207	244,044 Added 390.58%	306,526 $389,000
Q4 2022 Feb 14, 2023	BUY	$0.48 - $13.08 $29,991 - $817,264	62,482 New	62,482 $47,000
Q2 2022 Aug 16, 2022	BUY	$0.43 - $0.91 $17,468 - $36,968	40,625 New	40,625 $20,000
Q4 2020 Feb 17, 2021	SELL	$1.99 - $3.25 $60,088 - $98,133	-30,195 Closed	0 $0
Q3 2020 Nov 17, 2020	SELL	$2.85 - $4.1 $130,022 - $187,050	-45,622 Reduced 60.17%	30,195 $86,000
Q2 2020 Aug 17, 2020	BUY	$2.39 - $4.0 $104,392 - $174,716	43,679 Added 135.91%	75,817 $280,000
Q1 2020 May 15, 2020	BUY	$1.74 - $4.26 $55,920 - $136,907	32,138 New	32,138 $80,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.63B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.